Ibraheem Altamimi
Biographic Data
| ID | 7070023 |
|---|---|
| NAME | Ibraheem Altamimi |
| GIVEN NAMES | Ibraheem |
| FAMILY NAME | Altamimi |
| SIGNATURE | ALTAMIMI I |
| AFFILIATIONS | King Saud University |
| ORCID | 0000-0002-5149-0877 |
| VERIFIED | Yes |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Bacterial Pathogens and Antimicrobial Susceptibility Patterns of Urinary Tract Infections in Children during Covid-19 2019–2020
Our study recommends using local antibiotic sensitivity data for empirical UTI treatment. Amikacin, ertapenem, and meropenem are effective intravenous options. Cephalosporin, cefuroxime, amoxicillin/clavulanic acid, and nitrofurantoin are suitable oral choices. No significant changes in antimicrobial susceptibility were observed during the COVID-19 pandemic. Further research is needed to assess potential pandemic-related alterations
No prominent works on this page.
Bacterial Pathogens and Antimicrobial Susceptibility Patterns of Urinary Tract Infections in Children during Covid-19 2019–2020
Our study recommends using local antibiotic sensitivity data for empirical UTI treatment. Amikacin, ertapenem, and meropenem are effective intravenous options. Cephalosporin, cefuroxime, amoxicillin/clavulanic acid, and nitrofurantoin are suitable oral choices. No significant changes in antimicrobial susceptibility were observed during the COVID-19 pandemic. Further research is needed to assess potential pandemic-related alterations
Amikacin (1 work) · Antibiotic resistance (1 work) · Antibiotics (1 work) · Antimicrobial (1 work) · Biology (1 work) · Drug resistance (1 work) · Ertapenem (1 work) · Escherichia coli (1 work) · Fosfomycin (1 work) · Internal Medicine (1 work)